Pub. L. 92–255, title II, § 22486 Stat. 71Section 1134, , , , provided for establishment of research and development programs by Director.
Pub. L. 92–255, title II, § 22586 Stat. 72Section 1135, , , , provided for establishment of a single non-Federal share requirement.
Pub. L. 92–255, title II, § 22686 Stat. 72Section 1136, , , , provided for Director to make drug prevention function recommendations to President and to consult with responsible agencies with respect to drug prevention functions.
Pub. L. 92–255, title II, § 22786 Stat. 72Section 1137, , , , provided for resolution of agency conflicts with regard to drug prevention functions.
Pub. L. 92–255, title II, § 22886 Stat. 72Section 1138, , , , provided for communications and liaison with respect to drug prevention functions by one of Assistant Directors.
Pub. L. 92–255, title II, § 22986 Stat. 72Section 1139, , , , provided, with respect to drug prevention functions, coordination of State and local governments, availability of information and other services and activities.
Pub. L. 92–255, title II, § 23086 Stat. 73Section 1140, , , , provided for a management oversight review by a Federal officer.
Pub. L. 92–255, title II, § 23186 Stat. 73Section 1141, , , , provided for convening of a council of officials of Federal agencies responsible for drug prevention functions by Director.
Pub. L. 92–255, title II, § 23286 Stat. 73Section 1142, , , , provided for designation of the Director to represent Government in international negotiations related to drug prevention functions.
Pub. L. 92–255, title II, § 23386 Stat. 73Section 1143, , , , provided for an annual written report to the President by the Director.
Statutory Notes and Related Subsidiaries
Effective Date of Repeal
Section 1104 of this titlePub. L. 94–237, § 4(c)(1)90 Stat. 244, prior to repeal by , , , provided for repeal of sections effective .